Log In
Print
BCIQ
Print
Print this Print this
 

Xaluprine, mercaptopurine

  Manage Alerts
Collapse Summary General Information
Company Nova Laboratories Ltd.
DescriptionOral formulation of mercaptopurine, a DNA synthesis inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationAcute lymphoblastic leukemia (ALL)
Indication DetailsTreat acute lymphoblastic leukemia (ALL)
Regulatory Designation

EU - Orphan Drug (Treat acute lymphoblastic leukemia (ALL))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today